9th Circ. Says FDA Has Dibs On Copycat Drug Suits

By Katie Buehler (September 13, 2022, 6:40 PM EDT) -- A Ninth Circuit panel on Tuesday affirmed a California judge's decision to toss a pharmaceutical manufacturer's claims that a compounding pharmacy unlawfully produced copies of its U.S. Food and Drug Administration-approved blood pressure medication, ruling the claims were preempted by the FDA's exclusive enforcement power....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!